NCT02879747View on ClinicalTrials.gov

Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

March 31, 2012

Study Completion Date

December 31, 2017

Conditions
Short Stature
Interventions
DRUG

Genotropin

Children were randomized to either decreased dose by 50% or unchanged dose after 2-3 years of Catch-up growth

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Göteborg University

OTHER